IMPORTANT COVID INFORMATION: In an effort to ensure safety for our attendees and staff, this conference will be requiring attendees to show proof of COVID-19 vaccination at the conference. The conference will also be providing mandatory rapid COVID-19 testing upon arrival, prior to entering the event.

Virtual Live Stream & On-Demand Content

If you are having issues viewing our live stream, please click here

on-demand sessions

Biocom California Welcome Remarks

Joe Panetta President and CEO, Biocom California


Big Pharma Partnering in 2022

Lesley Stolz, Ph. D Regional Vice President, Early Innovation Partnering, Johnson & Johnson Innovation

Armin Rump Director of Global Business Development, Otsuka

Steve Bartz Vice President Corporate Development, Seattle Genetics

Imran Nasrullah, MS, JD Vice President & Head, Collaborate2Cure Hub US, Business Development & Licensing at Bayer Pharmaceuticals

John Wehrli Partner, Wilson Sonsini 


Mira Chaurushiya Senior Partner, Westlake Village BioPartners

Carol Gallagher Partner, New Enterprise Associates, Inc. (NEA)

Camille Samuels Partner, Venrock

Stefan Luzi Partner, Gilde Healthcare

Asish Xavier J&J Innovation – JJDC, Vice President, Venture Investments, Johnson & Johnson

Chau Quang Khuong Former Private Equity Partner, OrbiMed Advisors

Chris Nardo Managing Director, Life Sci Partners


Changing Lanes in Biotech Investing Panel Discussion

Scott Platshon Partner, EcoR1

Sarah Bhagat, PhD General Partner, Sofinnova

Dan Estes, Ph.D. General Partner, Frazier Healthcare Partners

Alex Szidon, PhD Chief Business Officer, Resilience

Scott Struthers Founder and CEO, Crinetics Pharmaceuticals

Cheston Larson Partner, Latham & Watkins

Keynote Speaker: Building Innovative Platform Companies and Medicines; An Academic’s Reflections

Benjamin F. Cravatt Professor and the Norton B. Gilula Chair of Chemical Biology in the Department of Chemistry at The Scripps Research Institute

Pharma’s Partnering Needs and Wants

Grace Han McMahon AVP and Head, Pacific Business Development & Licensing, Merck

Jay Stamatis, MBA Vice President, Head of Business Development and Acquisitions, AbbVie

Jeffrey Warmke, PhD Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo

Stephen C. Ferruolo Partner, Perkins Coie

Past, Present and Future of Vividion at Bayer: Unlocking Undruggable Targets

Marianne De Backer, PhD, MBA EVP Global Head, Strategy & Business Development, Bayer

Rich Heyman Former Chair, Vividion Therapeutics

Jeff Hatfield CEO, Vividion

Today’s VC Environment

Jeremy Caldwell President and CEO, Inception Therapeutics; Venture Partner, Versant Ventures

Katie Hewitt Chief Business Officer, Lilly New Ventures at Eli Lilly and Company

Shyam Masrani Principal, Medicxi

Hunter Reed Senior Associate – Alexandria Venture Investments

Jim Krenn Partner, Morrison & Foerster LLP

Watch the Keynote Panel from 2021 | The Power of Collaboration: Partnering to Save Patients in a Pandemic

  • Kate Bingham, Managing Director, SV Health Investors, Former Chair, UK Vaccine Task Forces
  • Moncef Slaoui, Partner, Medicxi, The Former Scientific Head, Operation Warp Speed
  • Moderated by: John Reed, MD, PhD, Executive Vice President, Global Head of Research & Development, Sanofi